Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (Asia Pacific)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (Asia Pacific)
‘The only danger here is snakes’ : where Orwell wrote Nineteen Eighty-Four – in pictures
5/11/2025
Wings by Paul McCartney review – a brilliant story of post-Beatles revival
5/11/2025
A moment that changed me : I thought I was a lesbian. David Bowie made me realise the truth
5/11/2025
‘Turn the volume up’ : Mamdani invokes Trump in fiery speech laying out plan of action
5/11/2025
I was trying to run for the presidency in Uganda – yet men still found the audacity to call me ‘baby, sweetheart, darling’ | Yvonne Mpambara
5/11/2025
‘People are always looking for a scapegoat’ : tensions rise in UK’s asylum and refugee hotspot
5/11/2025